Carotid atherosclerosis is not related to past tuberculosis in hypercholesterolemic patients

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 150-155

  Giral, Philippe ^a   Kahn, Jean François ^a   André, Jean Michel ^a   Carreau, Valérie ^a   Dourmap, Caroline ^a   Bruckert, Eric ^a   Chapman, M John ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Atherosclerosis; Hypercholesterolemia; Tuberculosis

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TUBERCULOSIS;

CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 33845448291     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.01.008     Document Type: Article

References (46)

1. Manolio T. Novel risk markers and clinical practice. N Engl J Med 349 (2003) 1587-1589
2. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
4. Binder C.J., Chang M.K., Shaw P.X., et al. Innate and acquired immunity in atherogenesis. Nat Med 11 (2002) 1218-1226
5. Libby P., and Hansson G.K. Involvment of the immune system in the human atherogenesis: current knowledge and unanswered question. Lab Invest 64 (1991) 5-15
6. Ludewig B., Krebs P., and Scandella E. Immunopathogenesis of atherosclerosis. J Leukoc Biol 76 (2004) 300-306
7. Palosuo T., Manninen V., and Saikku P. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 107 (2003) 2566-2570
8. Muhlestein J.B., Horne B.D., Carlquist J.F., et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102 (2000) 1917-1923
9. Hu H., Pierce G.N., and Zhong G. The atherogenic effects of chlamydia are dependant on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103 (1999) 747-753
10. Gupta S. Chronic infection in the aetiology of atherosclerosis-focus on Chlamydia pneumoniae. Atherosclerosis 143 (1999) 1-6
11. Danesh J., Whincup P., Walker M., et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321 (2000) 208-213
12. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., and Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
13. Poewe W., and Willeit J. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103 (2001) 1064-1070
14. Murray J.F. A century of tuberculosis. Am J Respir Crit Care Med 169 (2004) 1181-1186
15. Jasmer R.M., and Small P.M. A current approach to the management of tuberculosis infection. Curr Clin Top Infect Dis 20 (2000) 209-231
16. Leung A.N. Pulmonary tuberculosis: the essentials. Radiology 210 (1999) 307-322
17. Lawler W.R. An office approach to the diagnosis of chronic cough. Am Fam Physician 58 (1998) 2015-2022
18. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
19. Xu Q., Dietrich H., Steiner H.J., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb Vasc Biol 12 (1992) 789-799
20. George J., Shoenfeld G., Afek A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 19 (1999) 505-510
21. Broxmeyer L. Heart disease, the greatest risk factor of them all. Med. Hypotheses 62 (2004) 773-779
22. Zureik M., Touboul P.J., Bonithon-Kopp C., et al. Differential association of common carotid intima-media thickness and carotid atherosclerotic plaques with parental history of premature death from coronary heart disease: the EVA Study. Arterioscler Thromb Vasc Biol 19 (1999) 366-371
23. Bruckert E., Giral P., Salloum J., et al. Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis 92 (1992) 105-114
24. Beaudeux J.L., Giral P., Bruckert E., et al. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 169 (2003) 139-146
25. Blackburn R., Giral P., Bruckert E., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1962-1968
26. Giral P., Bruckert E., Dairou F., et al. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests. Am J Cardiol 84 (1999) 14-17
27. Anestad G., Hoel T., Scheel O., and Vainio K. Atherosclerosis and tuberculosis: are they both chronic infectious diseases?. Scand J Infect Dis 33 (2001) 797
28. O'Connor S. Fulfillment of Koch's postulates and the causes of atherosclerosis. Am Heart J 138 (1999) S550-S551
29. Ellis J.G. Plague (tuberculosis) and plaque (atherosclerosis). N Engl J Med 296 12 (1977) 695
30. Smith K.C., Armitige L., and Wanger A. A review of tuberculosis: reflections on the past, present and future of a global epidemic disease. Expert Rev Anti Infect Ther 1 (2003) 483-491
31. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
32. Epstein S.E., Zhou Y.F., and Zhu J. Infection and atherosclerosis-emerging mechanistic paradigms. Circulation 100 (1999) e20-e28
33. Anderson J.L. Infection, antibiotics, and atherothrombosis: end of the road or new beginnings?. N Engl J Med 352 (2005) 1706-1709
34. Berenson G.S., Srinivasan S.R., Bao W., et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 338 (1998) 1650-1656
35. Li S., Chen W., Srinivasan S.R., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290 (2003) 2271-2276
36. Knoflach M., Kiechl S., Kind M., et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 108 (2003) 1064-1069
37. Hoppichler F., Lechleitner M., Traweger C., et al. Changes of serum antibodies to heat-schock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 126 (1996) 333-338
38. Xu Q., Kiechl S., and Metzler B. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis-clinical significance determined in a follow up study. Circulation 100 (1999) 1169-1174
39. Xu Q., Willeit J., Marosi M., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341 (1993) 255-259
40. Bothamley G.H., Rudd R., Festenstein F., and Ivanyi J. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax 47 (1992) 270-275
41. Rook G.A., al Attiyah R., and Filley E. New insights into the immunopathology of tuberculosis. Pathobiology 59 (1991) 148-152
42. Afek A., George J., Gilburd B., et al. Immunization of low density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 14 (2000) 115-121
43. Cannon C.P., Braunwald E., McCabe C.H., et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 352 (2005) 1646-1654
44. Grayston J.T., Kronmal R.A., Jackson L.A., et al. ACES Investigators. Azithromycin for the secondary prevention of coronary events. N Engl J Med 352 (2005) 1637-1645
45. Carter J.D., Valeriano J., and Vasey F.B. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31 (2004) 1973-1980
46. Wolf K., and Malinverni R. Department effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. Antimicrob Agents Chemother 43 (1999) 1491-1493